Richard Pzena - Pzena Investment Management
Holding/activity history for Halozyme Therapeutics (HALO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 4,049 | <0.01 | Reduce 5.35% | $64.63 | $261,687 | SEC | |
| 2025 Q4 | 4,278 | <0.01 | Add 4.16% | $67.30 | $287,909 | SEC | |
| 2025 Q3 | 4,107 | <0.01 | Buy | <0.01 | $73.34 | $301,207 | SEC |
| 2023 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2023 Q1 | 9,216 | <0.01 | Reduce 36.47% | <0.01 | $38.19 | $351,959 | SEC |
| 2022 Q4 | 14,507 | <0.01 | Buy | <0.01 | $56.90 | $825,448 | SEC |
| 2022 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2022 Q1 | 15,738 | <0.01 | Buy | <0.01 | $39.90 | $628,000 | SEC |